A Randomized-Controlled Trial to Increase the Uptake of LARCs in Cameroon
NCT ID: NCT03733678
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2500 participants
INTERVENTIONAL
2021-03-23
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study investigators propose to use an integrated behavioral science approach to increase the take-up of both SARCs (short-acting reversible contraceptives, i.e. the pill and injectable) and especially LARCs among reproductive-age females in Cameroon, including adolescents who may be unmarried and/or nulliparous. In addition to decreasing maternal mortality and undesired pregnancies, indirect effects for the community will include: increased welfare from reduced side effects that arise due to current one-size-fits-all FP counseling; healthier children due to improved birth spacing; and increased human capital formation both for children and for young (often school-aged) potential mothers.
The study investigators propose to conduct the study at HGOPY for a duration of 12 months. The study investigators will provide tablets to each of five nurses that conduct FP counseling to participants at the hospital. The tablets contain a counseling "app" (or decision-support tool or a job-aid) that was jointly developed by professionals from HGOPY, the World Bank, and the Ministry of Health. The study investigators propose an individually-randomized experiment, where the participants will be offered randomly varying discounts for the modern contraceptive methods they wish to adopt. The study investigators also propose to experiment with certain aspects of the "app" to improve its effectiveness - both for the participant and for the nurse. More details on the experimental design are provided below.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rigorous Evaluation of Let's Talk Birth Control
NCT06670066
Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk
NCT03372369
Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian Women
NCT01893021
LARC Forward Counselling
NCT03269357
Improving Uptake of Antenatal Care Services in Rural Côte d'Ivoire
NCT07341581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
1. First, a tablet-based counseling app that is used by the provider gives random discounts to clients - separately for LARCs and SARCs.
2. Second, the tablet-based app presents recommendations to the client sequentially (i.e. the top-ranked method, followed by the next one if that recommendation is declined by the client, etc.) vs. simultaneously (i.e. presenting the top recommendations to the client all at once and asking her to choose which one to discuss further).
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Free SARC, Free LARC, Recommendation
Free SARC, Free LARC, Sequential recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Free SARC, LARC=500, Recommendation
Free SARC, LARC=500 CFA, Sequential recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Free SARC, LARC=1000, Recommendation
Free SARC, LARC=1000 CFA, Sequential recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Free SARC, LARC=2140, Recommendation
Free SARC, LARC=2140 CFA, Sequential recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Free SARC, LARC=5000, Recommendation
Free SARC, LARC=5000 CFA, Sequential recommendation
Price discounts for SARCs
SARCs are offered free to the client
Regular SARC, Free LARC, Recommendation
Regular price SARC, Free LARC, Sequential recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Regular SARC, LARC=500, Recommendation
Regular price SARC, LARC=500 CFA, Sequential recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Regular SARC, LARC=1000, Recommendation
Regular price SARC, LARC=1000 CFA, Sequential recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Regular SARC, LARC=2140, Recommendation
Regular price SARC, LARC=2140 CFA, Sequential recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Regular SARC, LARC=5000, Recommendation
Regular price SARC, LARC=5000 CFA, Sequential recommendation
No interventions assigned to this group
Free SARC, Free LARC, No Recommendation
Free SARC, Free LARC, Simultaneous recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Free SARC, LARC=500, No Recommendation
Free SARC, LARC=500 CFA, Simultaneous recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Free SARC, LARC=1000, No Recommendation
Free SARC, LARC=1000 CFA, Simultaneous recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Free SARC, LARC=2140, No Recommendation
Free SARC, LARC=2140 CFA, Simultaneous recommendation
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Free SARC, LARC=5000, No Recommendation
Free SARC, LARC=5000 CFA, Simultaneous recommendation
Price discounts for SARCs
SARCs are offered free to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Regular SARC, Free LARC, No Recommendation
Regular Price SARC, Free LARC, Simultaneous recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Regular SARC, LARC=500, No Recommendation
Regular Price SARC, LARC=500 CFA, Simultaneous recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Regular SARC, LARC=1000, No Recommendation
Regular Price SARC, LARC=1000 CFA, Simultaneous recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Regular SARC, LARC=2140, No Recommendation
Regular Price SARC, LARC=2140 CFA, Simultaneous recommendation
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Regular SARC, LARC=5000, No Recommendation
Regular Price SARC, LARC=5000 CFA, Simultaneous recommendation
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Price discounts for SARCs
SARCs are offered free to the client
Price discounts for LARCs
LARCs are offered at lower prices to the client
Sequential vs. simultaneous recommendations
Top ranked methods are presented to the client sequentially or simultaneously
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 10-49
* Presenting at HGOPY seeking FP counseling/services
* HGOPY clients referred to the family planning unit for consultation
10 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
George Washington University
OTHER
University of Exeter
OTHER
University of California, San Diego
OTHER
Yaounde Gynecology, Obstetrics and Pediatrics Hospital
UNKNOWN
World Bank
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Berk Ozler
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Berk Ozler, PhD
Role: PRINCIPAL_INVESTIGATOR
World Bank
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital gynéco-obstétrique et pédiatrique de Yaoundé (HGOPY)
Yaoundé, , Cameroon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LARCs-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.